Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Concentrix (CNXC) EBITDA (2020 - 2026)

Concentrix's EBITDA history spans 7 years, with the latest figure at $118.6 million for Q1 2026.

  • On a quarterly basis, EBITDA fell 29.79% to $118.6 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$968.5 million, a 257.01% decrease, with the full-year FY2025 number at -$918.2 million, down 253.96% from a year prior.
  • EBITDA hit $118.6 million in Q1 2026 for Concentrix, up from -$1.4 billion in the prior quarter.
  • Over the last five years, EBITDA for CNXC hit a ceiling of $180.4 million in Q4 2023 and a floor of -$1.4 billion in Q4 2025.
  • Historically, EBITDA has averaged $64.6 million across 5 years, with a median of $153.2 million in 2024.
  • Biggest five-year swings in EBITDA: increased 22.37% in 2022 and later tumbled 1056.43% in 2025.
  • Tracing CNXC's EBITDA over 5 years: stood at $178.0 million in 2022, then grew by 1.38% to $180.4 million in 2023, then fell by 19.9% to $144.5 million in 2024, then tumbled by 1056.43% to -$1.4 billion in 2025, then skyrocketed by 108.58% to $118.6 million in 2026.
  • Business Quant data shows EBITDA for CNXC at $118.6 million in Q1 2026, -$1.4 billion in Q4 2025, and $147.0 million in Q3 2025.